arrow
I

Inge M.W. Verberk

vrije universiteit amsterdam
H指数:29
被引数:4,538

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration

乙酰化Tau-174 CSF生物标志物区分额颞叶变性患者的TDP-43和tau病理

2026-04-150
OAAI
Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury

血清NfL、GFAP和p-tau217在药物难治性癫痫及智力障碍成人中的研究:持续神经损伤的标志

2026-03-300
OAAI
Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderly

基于血浆生物标志物对非痴呆老年人临床进展至痴呆的个体化预测

2025-12-030
OA
Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium

Verberk, I.M.W.; Gouda, M.; Antwi-Berko, D.; van Leeuwenstijn, M.; Bongers, B.; Houtkamp, I.M.; van der Flier, W.M.; Janelidze, S.; Hansson, O.; Bastard, N.L.; 等. 基于证据的标准化样本处理协议,用于准确测量血液中阿尔茨海默病的生物标志物:全球生物标志物标准化联盟的结果与共识。Alzheimers Dement. 2025, 21, e70752. [Google Scholar] [CrossRef] [PubMed]

2025-09-304
OAAI
Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217

八种sim0a的分析和临床表现®和Lumipulse®血浆p-tau181和p-tau217的自动测量分析

2024-12-190
OAAI
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic
2024-08-210
OAAI
Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice
2024-08-030
OA
Adaptive immune changes associate with clinical progression of Alzheimer's disease
2024-04-242
OAAI
Biomarker-based staging of Alzheimer disease: rationale and clinical applications

基于生物标志物的阿尔茨海默病分期: 基本原理和临床应用

2024-03-0120
PRE
Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: The SMART-MR Study

阿尔茨海默氏病病理,神经元损伤和星形胶质细胞激活的血浆标志物以及血管病理和神经变性的MRI负荷: smart-mr研究

2024-02-205
OAAI